Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology.

Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology.

COVID-19 caused by the SARS-CoV-2 virus is widespread in all regions, and it disturbs host immune system functioning leading to extreme inflammatory reaction and hyperactivation of the immune response. Kabasura Kudineer (KSK) is preventive medicine against viral infections and a potent immune booste...

Full description

Bibliographic Details
Main Authors: Vidhya Rajalakshmi V, Akilandeswari Ramu, Jayaprakash Chinnappan, Palanivel Velmurugan, Rajiv Pathak, Rami Adel Pashameah, Atif Abdulwahab A Oyouni, Osama M Al-Amer, Mohammed I Alasseiri, Abdullah Hamadi, Mansuor A Alanazi, Thangavelu Sathiamoorthi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0282263

Internet

https://doi.org/10.1371/journal.pone.0282263

Similar Items